{"id":815570,"date":"2025-02-20T08:22:33","date_gmt":"2025-02-20T13:22:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/"},"modified":"2025-02-20T08:22:33","modified_gmt":"2025-02-20T13:22:33","slug":"immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/","title":{"rendered":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024"},"content":{"rendered":"

\nConference Call Scheduled for Wednesday, February 26, 2025 at 9:00 AM ET
\n<\/h2>\n
\n

PORTLAND, Maine, Feb. 20, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq:\u00a0ICCC) <\/strong>(\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter and year ended December 31, 2024 after the market closes on Tuesday, February 25, 2025.<\/p>\n

The Company is planning to host a conference call the next morning, Wednesday, February 26, 2025, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET. A teleconference replay of the call will be available until March 5, 2025 at (877) 344-7529 (toll free) or (412) 317-0088 (international), utilizing replay access code #5555700.<\/p>\n

The Company anticipates no change to the preliminary sales results for the fourth quarter and year ended December 31, 2024 that were disclosed on January 9, 2025. The Company expects to file its Annual Report on Form 10-K on or before Monday, March 31, 2025.<\/p>\n

Investors are encouraged to review the Company\u2019s updated Corporate Presentation slide deck that provides an overview of the Company\u2019s business which can be accessed under the \u201cInvestors\u201d tab of the Company\u2019s website at www.immucell.com<\/a>, or by request to the Company. An updated version of the slide deck will be made available after the market closes on Tuesday, February 25, 2025.<\/p>\n

\n
\n About ImmuCell:<\/u>
\n <\/strong>
\n
ImmuCell Corporation’s (Nasdaq: ICCC<\/strong>) purpose is to create scientifically proven and practical products that improve the health and productivity of dairy and beef calves.\u00a0 ImmuCell manufactures and markets First Defense<\/strong>\u00ae<\/sup>, providing Immediate Immunity<\/strong>\u2122 to newborn dairy and beef calves, and is developing Re-Tain<\/strong>\u00ae<\/sup>, a novel treatment for subclinical mastitis in dairy cows without FDA-required milk discard or meat withhold label restrictions that provides an alternative to traditional antibiotics. Press releases and other information about the Company are available at: http:\/\/www.immucell.com<\/u><\/a>.<\/p>\n\n\n\n\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Contacts:<\/strong>\n <\/td>\nMichael F. Brigham, President and CEO
ImmuCell Corporation
(207) 878-2770<\/p>\n

Joe Diaz, Robert Blum and Joe Dorame
Lytham Partners, LLC
(602) 889-9700
iccc@lythampartners.com<\/a><\/td>\n<\/tr>\n

\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Conference Call Scheduled for Wednesday, February 26, 2025 at 9:00 AM ET PORTLAND, Maine, Feb. 20, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter and year ended December 31, 2024 after the market closes on Tuesday, February 25, 2025. The Company is planning to host a conference call the next morning, Wednesday, February 26, 2025, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) … <\/p>\n

Continue reading “ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815570","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference Call Scheduled for Wednesday, February 26, 2025 at 9:00 AM ET PORTLAND, Maine, Feb. 20, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter and year ended December 31, 2024 after the market closes on Tuesday, February 25, 2025. The Company is planning to host a conference call the next morning, Wednesday, February 26, 2025, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) … Continue reading "ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T13:22:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024\",\"datePublished\":\"2025-02-20T13:22:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/\"},\"wordCount\":354,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/\",\"name\":\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=\",\"datePublished\":\"2025-02-20T13:22:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/","og_locale":"en_US","og_type":"article","og_title":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024 - Market Newsdesk","og_description":"Conference Call Scheduled for Wednesday, February 26, 2025 at 9:00 AM ET PORTLAND, Maine, Feb. 20, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter and year ended December 31, 2024 after the market closes on Tuesday, February 25, 2025. The Company is planning to host a conference call the next morning, Wednesday, February 26, 2025, at 9:00 AM ET to review the unaudited financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) … Continue reading \"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T13:22:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024","datePublished":"2025-02-20T13:22:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/"},"wordCount":354,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/","name":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=","datePublished":"2025-02-20T13:22:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTc5NCM2NzYwNTQ3IzIwODk4MDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-and-year-ended-december-31-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter and Year Ended December 31, 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815570"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815570\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}